Clinical Trial Update: A Study to Find the Best Dose of BI 905711 in Combination With Chemotherapy and to Test Whether This Dose Helps People With Advanced Gastrointestinal Cancers [Phase 1]

View source ↗

Summary

Phase 1 study to identify the recommended dose of BI 905711 in combination with chemotherapy for advanced/metastatic gastrointestinal cancers; results have been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Gastrointestinal Cancer

Drugs mentioned

• BI-905711

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Gastrointestinal Cancer, Metastatic | Phase 1 | Status: COMPLETED | Results posted: 2025-02-19